- Service Name
DPP® HIV-Syphilis
- Industry
Healthcare, Diagnostics, Infectious Disease Testing, Point-of-Care Testing
- Main Value Proposition
Chembio Diagnostics offers innovative and reliable point-of-care diagnostic solutions that enhance health outcomes by enabling rapid detection of infectious diseases.
- Description
DPP® HIV-Syphilis is a rapid diagnostic test that detects both HIV and syphilis in a single test. It is the first and only FDA-approved, CLIA-waived HIV-Syphilis rapid test, designed for ease of use and quick results.
- Key Features
First and only FDA-approved, CLIA-waived HIV-Syphilis rapid test; Fast and accurate results; Designed for ease of use with fingerstick whole blood; Part of a comprehensive range of point-of-care diagnostic solutions
- Use Cases
Testing for HIV and syphilis in clinics and community health settings; Rapid screening in emergency situations; Point-of-care testing in remote or underserved areas
- Competitive advantages
Unique CLIA-waived status for the DPP® HIV-Syphilis test; Comprehensive product range covering multiple infectious diseases; Strong focus on point-of-care testing, making diagnostics accessible and efficient
- Strengths
Chembio Diagnostics is recognized for its innovative approach to rapid diagnostics, commitment to quality, and ability to deliver products that are both user-friendly and effective in various healthcare settings.
- Positioning
Chembio Diagnostics positions itself as a leader in point-of-care diagnostics, emphasizing rapid and accurate testing solutions that improve health outcomes.
- Audience
The primary target users include healthcare providers, clinics, and community health organizations focused on infectious disease prevention and management.
- CTA
Contact your local Chembio Representative for more information
- Tags
Rapid Testing
Infectious Diseases
Point-of-Care
Diagnostic Solutions
- Tagline
We enable longer and healthier living through detection and monitoring of infectious diseases at the point of care.
- Tone of Voice
Professional, informative, innovative
- Differentiation
Chembio Diagnostics stands out in the market by providing the only CLIA-waived HIV-Syphilis rapid test, which allows for testing in various settings without the need for complex laboratory equipment.
- Brand Positioning
Chembio Diagnostics is identified as a reliable and innovative brand in the health diagnostics sector, committed to enhancing public health through advanced diagnostic technologies.
- Founded
1986-01-01